LDL Promotes Disorders in β-Cell Cholesterol Metabolism, Implications on Insulin Cellular Communication Mediated by EVs

• Published in: Metabolites 2022-08, Vol.12 (8), p.754
• Main Authors: Guevara-Olaya, Lizbeth, Chimal-Vega, Brenda, Castañeda-Sánchez, César Yahel, López-Cossio, Leslie Y, Pulido-Capiz, Angel, Galindo-Hernández, Octavio, Díaz-Molina, Raúl, Ruiz Esparza-Cisneros, Josefina, García-González, Victor
• Format: Article
• Language: English
• Subjects: ABCA1 protein; Angiotensin; ATP-binding protein; Beta cells; Biosynthesis; Ca2+-transporting ATPase; Calcium (intracellular); Cell interactions; Cholesterol; Cholesterol metabolism; Cholesterol, LDL; Communication; Complications and side effects; Cytokines; Diagnosis; Dyslipidemia; Endocytosis; Endoplasmic reticulum; Esterification; Experiments; Health aspects; Hepatocytes; High density lipoprotein; Homeostasis; Hyperactivity; Hypercholesterolemia; Insulin; Insulin resistance; Insulin secretion; Interleukin 6; Intracellular; Intracellular levels; LDL; Lipid metabolism; Lipids; Lipoproteins; Metabolic syndrome; Metabolism; metainflammation; Na+/Ca2+ exchanger; NF-κB protein; Obesity; Pancreas; PDX-1; Protein folding; Proteins; Regulation; Renin; Risk factors; TOR protein; Type 2 diabetes; β-cells
• ISSN: 2218-1989; 2218-1989
• DOI: 10.3390/metabo12080754

Dyslipidemia is described as a hallmark of metabolic syndrome, promoting a stage of metabolic inflammation (metainflammation) that could lead to misbalances in energetic metabolism, contributing to insulin resistance, and modifying intracellular cholesterol pathways and the renin-angiotensin system (RAS) in pancreatic islets. Low-density lipoprotein (LDL) hypercholesterolemia could disrupt the tissue communication between Langerhans β-cells and hepatocytes, wherein extracellular vesicles (EVs) are secreted by β-cells, and exposition to LDL can impair these phenomena. β-cells activate compensatory mechanisms to maintain insulin and metabolic homeostasis; therefore, the work aimed to characterize the impact of LDL on β-cell cholesterol metabolism and the implication on insulin secretion, connected with the regulation of cellular communication mediated by EVs on hepatocytes. Our results suggest that β-cells can endocytose LDL, promoting an increase in cholesterol synthesis targets. Notably, LDL treatment increased mRNA levels and insulin secretion; this hyperinsulinism condition was associated with the transcription factor PDX-1. However, a compensatory response that maintains basal levels of intracellular calcium was described, mediated by the overexpression of calcium targets PMCA1/4, SERCA2, and NCX1, together with the upregulation of the unfolded protein response (UPR) through the activation of IRE1 and PERK arms to maintain protein homeostasis. The LDL treatment induced metainflammation by IL-6, NF-κB, and COX-2 overexpression. Furthermore, LDL endocytosis triggered an imbalance of the RAS components. LDL treatment increased the intracellular levels of cholesterol on lipid droplets; the adaptive β-cell response was portrayed by the overexpression of cholesterol transporters ABCA1 and ABCG1. Therefore, lipotoxicity and hyperinsulinism induced by LDL were regulated by the natural compound auraptene, a geranyloxyn coumarin modulator of cholesterol-esterification by ACAT1 enzyme inhibition. EVs isolated from β-cells impaired insulin signaling via mTOR/p70S6Kα in hepatocytes, a phenomenon regulated by auraptene. Our results show that LDL overload plays a novel role in hyperinsulinism, mechanisms associated with a dysregulation of intracellular cholesterol, lipotoxicity, and the adaptive UPR, which may be regulated by coumarin-auraptene; these conditions explain the affectations that occur during the initial stages of insulin resistance.